These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 21905034)

  • 21. Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice.
    Flick-Smith HC; Eyles JE; Hebdon R; Waters EL; Beedham RJ; Stagg TJ; Miller J; Alpar HO; Baillie LW; Williamson ED
    Infect Immun; 2002 Apr; 70(4):2022-8. PubMed ID: 11895967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a novel multiepitope chimeric vaccine against anthrax.
    Aggarwal S; Somani VK; Gupta S; Garg R; Bhatnagar R
    Med Microbiol Immunol; 2019 Apr; 208(2):185-195. PubMed ID: 30671633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and immunogenicity of single-dose AdVAV intranasal anthrax vaccine compared to anthrax vaccine absorbed in an aerosolized spore rabbit challenge model.
    Krishnan V; Andersen BH; Shoemaker C; Sivko GS; Tordoff KP; Stark GV; Zhang J; Feng T; Duchars M; Roberts MS
    Clin Vaccine Immunol; 2015 Apr; 22(4):430-9. PubMed ID: 25673303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of particulate adjuvant on the anthrax protective antigen dose required for effective nasal vaccination.
    Bento D; Staats HF; Borges O
    Vaccine; 2015 Jul; 33(31):3609-13. PubMed ID: 26087299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli.
    Sloat BR; Cui Z
    Vaccine; 2006 Sep; 24(40-41):6405-13. PubMed ID: 16828937
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.
    Sloat BR; Shaker DS; Le UM; Cui Z
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against anthrax by needle-free mucosal immunization with human anthrax vaccine.
    Zeng M; Xu Q; Pichichero ME
    Vaccine; 2007 May; 25(18):3588-94. PubMed ID: 17293013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of protective immunity against lethal anthrax challenge with a patch.
    Kenney RT; Yu J; Guebre-Xabier M; Frech SA; Lambert A; Heller BA; Ellingsworth LR; Eyles JE; Williamson ED; Glenn GM
    J Infect Dis; 2004 Aug; 190(4):774-82. PubMed ID: 15272406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.
    Oscherwitz J; Feldman D; Yu F; Cease KB
    Vaccine; 2015 Jan; 33(3):430-6. PubMed ID: 25454087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.
    Baillie LW; Rodriguez AL; Moore S; Atkins HS; Feng C; Nataro JP; Pasetti MF
    Vaccine; 2008 Nov; 26(48):6083-91. PubMed ID: 18805452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of aluminum hydroxide adjuvant and formaldehyde in the formulation of rPA anthrax vaccine.
    Little SF; Ivins BE; Webster WM; Norris SL; Andrews GP
    Vaccine; 2007 Apr; 25(15):2771-7. PubMed ID: 17240008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biophysical characterization and immunization studies of dominant negative inhibitor (DNI), a candidate anthrax toxin subunit vaccine.
    Iyer V; Hu L; Schanté CE; Vance D; Chadwick C; Jain NK; Brey RN; Joshi SB; Volkin DB; Andra KK; Bann JG; Mantis NJ; Middaugh CR
    Hum Vaccin Immunother; 2013 Nov; 9(11):2362-70. PubMed ID: 23925275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin.
    Gaur R; Gupta PK; Banerjea AC; Singh Y
    Vaccine; 2002 Jun; 20(21-22):2836-9. PubMed ID: 12034111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative immunogenicity and efficacy of thermostable (lyophilized) and liquid formulation of anthrax vaccine candidate AV7909.
    Autumn Smiley M; Sanford DC; Triplett CA; Callahan D; Frolov V; Look J; Ruiz C; Reece JJ; Miles A; Ruiz E; Ionin B; Shearer JD; Savransky V
    Vaccine; 2019 Oct; 37(43):6356-6361. PubMed ID: 31530467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine.
    Mikszta JA; Dekker JP; Harvey NG; Dean CH; Brittingham JM; Huang J; Sullivan VJ; Dyas B; Roy CJ; Ulrich RG
    Infect Immun; 2006 Dec; 74(12):6806-10. PubMed ID: 17030580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stabilization of alum-adjuvanted vaccine dry powder formulations: mechanism and application.
    Maa YF; Zhao L; Payne LG; Chen D
    J Pharm Sci; 2003 Feb; 92(2):319-32. PubMed ID: 12532382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trimethyl Chitosan Nanoparticles Encapsulated Protective Antigen Protects the Mice Against Anthrax.
    Malik A; Gupta M; Mani R; Gogoi H; Bhatnagar R
    Front Immunol; 2018; 9():562. PubMed ID: 29616046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.
    Williamson ED; Hodgson I; Walker NJ; Topping AW; Duchars MG; Mott JM; Estep J; Lebutt C; Flick-Smith HC; Jones HE; Li H; Quinn CP
    Infect Immun; 2005 Sep; 73(9):5978-87. PubMed ID: 16113318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of three anthrax toxin neutralization assays.
    Ngundi MM; Meade BD; Lin TL; Tang WJ; Burns DL
    Clin Vaccine Immunol; 2010 Jun; 17(6):895-903. PubMed ID: 20375243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intranasal immunization with aluminum salt-adjuvanted dry powder vaccine.
    Thakkar SG; Warnken ZN; Alzhrani RF; Valdes SA; Aldayel AM; Xu H; Williams RO; Cui Z
    J Control Release; 2018 Dec; 292():111-118. PubMed ID: 30339906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.